Predictors of postoperative seizure outcome in supratentorial meningioma

View More View Less
  • 1 Department of Neurosurgery, Baylor College of Medicine, Houston;
  • | 2 Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, Texas;
  • | 3 Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania; and
  • | 4 Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
USD  $45.00
USD  $515.00
USD  $612.00
Print or Print + Online Sign in

OBJECTIVE

Meningiomas are the most common primary intracranial tumor. Seizures are common sequelae of meningioma development. Meningioma patients with seizures can be effectively treated with resection, with reports of seizure freedom of 60%–90%. Still, many patients manifest persistent epilepsy. Determining factors associated with worsened seizure outcomes remains critical in improving the quality of life for these patients. The authors sought to identify clinical, radiological, and histological factors associated with worse seizure outcomes in patients with supratentorial meningioma and preoperative seizures.

METHODS

The authors retrospectively reviewed the charts of 384 patients who underwent meningioma resection from 2008 to 2020. The charts of patients with a documented history of preoperative seizures were further reviewed for clinical, radiological, operative, perioperative, histological, and postoperative factors associated with seizures. Engel class at last follow-up was retrospectively assigned by the authors and further grouped into favorable (class I) and worse (class II–IV) outcomes. Factors were subsequently compared by group using comparative statistics. Univariable and multivariable regression models were utilized to identify independent predictors of worse seizure outcome.

RESULTS

Fifty-nine patients (15.4%) were found to have preoperative seizures, of whom 57 had sufficient postoperative data to determine Engel class outcome. Forty-two patients (74%) had Engel class I outcomes. The median follow-up was 17 months. Distinct margins on preoperative imaging (p = 0.012), Simpson grade I resection (p = 0.004), postresection ischemia (p = 0.019), WHO grade (p = 0.019), and recurrent disease (p = 0.015) were found to be the strongest predictors of Engel class outcome in univariable logistic regression. MIB-1 index (p = 0.001) and residual volume (p = 0.014) at last follow-up were found to be the strongest predictors of Engel class outcome in univariable generalized linear regression. Postresection ischemia (p = 0.012), WHO grade (p = 0.022), recurrent disease (p = 0.038), and MIB-1 index (p = 0.002) were found to be the strongest independent predictors of Engel class outcomes in multivariable analysis.

CONCLUSIONS

Postresection ischemia, higher WHO grade, elevated MIB-1 index, and disease recurrence independently predict postresection seizure persistence in patients with supratentorial meningioma. Further understanding of the etiology of these markers may aid in elucidation of this complex disease process and guide management to prevent worse outcomes.

ABBREVIATIONS

AED = antiepileptic drug; FND = functional neurological deficit.

Images from Minchev et al. (pp 479–488).

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
USD  $515.00
USD  $612.00
  • 1

    Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010;99(3):307314.

  • 2

    Holleczek B, Zampella D, Urbschat S, Sahm F, von Deimling A, Oertel J, Ketter R. Incidence, mortality and outcome of meningiomas: a population-based study from Germany. Cancer Epidemiol. 2019;62:101562.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Chen WC, Magill ST, Englot DJ, Baal JD, Wagle S, Rick JW, McDermott MW. Factors associated with pre- and postoperative seizures in 1033 patients undergoing supratentorial meningioma resection. Neurosurgery. 2017;81(2):297306.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Englot DJ, Magill ST, Han SJ, Chang EF, Berger MS, McDermott MW. Seizures in supratentorial meningioma: a systematic review and meta-analysis. J Neurosurg. 2016;124(6):15521561.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Xue H, Sveinsson O, Tomson T, Mathiesen T. Intracranial meningiomas and seizures: a review of the literature. Acta Neurochir (Wien). 2015;157(9):15411548.

    • Search Google Scholar
    • Export Citation
  • 6

    Skardelly M, Rother C, Noell S, Behling F, Wuttke TV, Schittenhelm J, et al. Risk factors of preoperative and early postoperative seizures in patients with meningioma: a retrospective single-center cohort study. World Neurosurg. 2017;97:538546.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Li X, Wang C, Lin Z, Zhao M, Ren X, Zhang X, Jiang Z. Risk factors and control of seizures in 778 Chinese patients undergoing initial resection of supratentorial meningiomas. Neurosurg Rev. 2020;43(2):597608.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Gupte TP, Li C, Jin L, Yalcin K, Youngblood MW, Miyagishima DF, et al. Clinical and genomic factors associated with seizures in meningiomas. J Neurosurg. 2020;135(3):835844.

    • Search Google Scholar
    • Export Citation
  • 9

    Hwang K, Joo JD, Kim YH, Han JH, Oh CW, Yun CH, et al. Risk factors for preoperative and late postoperative seizures in primary supratentorial meningiomas. Clin Neurol Neurosurg. 2019;180:3439.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Schneider M, Güresir Á, Borger V, Hamed M, Rácz A, Vatter H, et al. Preoperative tumor-associated epilepsy in patients with supratentorial meningioma: factors influencing seizure outcome after meningioma surgery. J Neurosurg. 2020;133(6):16551661.

    • Search Google Scholar
    • Export Citation
  • 11

    Wirsching HG, Morel C, Gmür C, Neidert MC, Baumann CR, Valavanis A, et al. Predicting outcome of epilepsy after meningioma resection. Neuro Oncol. 2016;18(7):10021010.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Chaichana KL, Pendleton C, Zaidi H, Olivi A, Weingart JD, Gallia GL, et al. Seizure control for patients undergoing meningioma surgery. World Neurosurg. 2013;79(3-4):515524.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Zheng Z, Chen P, Fu W, Zhu J, Zhang H, Shi J, Zhang J. Early and late postoperative seizure outcome in 97 patients with supratentorial meningioma and preoperative seizures: a retrospective study. J Neurooncol. 2013;114(1):101109.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Sheth RD. Epilepsy surgery. Presurgical evaluation. Neurol Clin. 2002;20(4):11951215.

  • 15

    Kanchanatawan B, Limothai C, Srikijvilaikul T, Maes M. Clinical predictors of 2-year outcome of resective epilepsy surgery in adults with refractory epilepsy: a cohort study. BMJ Open. 2014;4(4):e004852.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Engel J. Seizures and Epilepsy. 2nd ed. Contemporary Neurology Series.Oxford University Press;2013.

  • 17

    Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):2239.

  • 18

    Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803820.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):12311251.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg. 2015;122(1):423.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Morris Z, Whiteley WN, Longstreth WT Jr, Weber F, Lee YC, Tsushima Y, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, et al. Advances in multidisciplinary therapy for meningiomas. Neuro Oncol. 2019;21(1)(suppl 1):i18i31.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Klinger NV, Shah AK, Mittal S. Management of brain tumor-related epilepsy. Neurol India. 2017;65(suppl):S60S70.

  • 24

    Gallagher P, Leach JP, Grant R. Time to focus on brain tumor-related epilepsy trials. Neurooncol Pract. 2014;1(3):123133.

  • 25

    Giulioni M, Marucci G, Martinoni M, Marliani AF, Toni F, Bartiromo F, et al. Epilepsy associated tumors: review article. World J Clin Cases. 2014;2(11):623641.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Aronica E, Leenstra S, van Veelen CW, van Rijen PC, Hulsebos TJ, Tersmette AC, et al. Glioneuronal tumors and medically intractable epilepsy: a clinical study with long-term follow-up of seizure outcome after surgery. Epilepsy Res. 2001;43(3):179191.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Neuberger EJ, Gupta A, Subramanian D, Korgaonkar AA, Santhakumar V. Converging early responses to brain injury pave the road to epileptogenesis. J Neurosci Res. 2019;97(11):13351344.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Watts J, Box G, Galvin A, Brotchie P, Trost N, Sutherland T. Magnetic resonance imaging of meningiomas: a pictorial review. Insights Imaging. 2014;5(1):113122.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Nakano T, Asano K, Miura H, Itoh S, Suzuki S. Meningiomas with brain edema: radiological characteristics on MRI and review of the literature. Clin Imaging. 2002;26(4):243249.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30

    Pallud J, Capelle L, Huberfeld G. Tumoral epileptogenicity: how does it happen?. Epilepsia. 2013;54(suppl 9):3034.

  • 31

    Das A, Kesavadas C. Perilesional brain oedema and seizure activity: cause or effect?. Lancet Neurol. 2009;8(3):225226.

  • 32

    Robel S. Astroglial scarring and seizures: a cell biological perspective on epilepsy. Neuroscientist. 2017;23(2):152168.

  • 33

    Xu MY. Poststroke seizure: optimising its management. Stroke Vasc Neurol. 2018;4(1):4856.

  • 34

    Blümcke I, Aronica E, Miyata H, Sarnat HB, Thom M, Roessler K, et al. International recommendation for a comprehensive neuropathologic workup of epilepsy surgery brain tissue: a consensus Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia. 2016;57(3):348358.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Coons SW, Johnson PC, Pearl DK. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. Neurosurgery. 1997;41(4):878885.

  • 36

    Patel AJ, Wan YW, Al-Ouran R, Revelli JP, Cardenas MF, Oneissi M, et al. Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Proc Natl Acad Sci U S A. 2019;116(43):2171521726.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Viaene AN, Zhang B, Martinez-Lage M, Xiang C, Tosi U, Thawani JP, et al. Transcriptome signatures associated with meningioma progression. Acta Neuropathol Commun. 2019;7(1):67.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38

    Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 2017;18(5):682694.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39

    Olar A, Wani KM, Wilson CD, Zadeh G, DeMonte F, Jones DT, et al. Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathol. 2017;133(3):431444.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40

    Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, et al. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro Oncol. 2019;21(7):901910.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    Khan AB, Gadot R, Shetty A, Bayley JC V, Hadley CC, Cardenas MF, et al. Identification of novel fusion transcripts in meningioma. J Neurooncol. 2020;149(2):219230.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42

    Youngblood MW, Miyagishima DF, Jin L, Gupte T, Li C, Duran D, et al. Associations of meningioma molecular subgroup and tumor recurrence. Neuro Oncol. 2021;23(5):783794.

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 1987 1987 219
Full Text Views 245 245 50
PDF Downloads 307 307 72
EPUB Downloads 0 0 0